To further characterize the phenotype of FOXP3-positive cells detected in CRC lesions, immunofluorescence double staining was performed using antibodies specific for CD8/FOXP3, and CD3/FOXP3 as a control. This evidence concerns the gene FOXP3 and colorectal carcinoma.